切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - eIF4F - Cytochrome P450 (CYP450) - eIF4E/eIF3G interaction - Urokinases

18件产品中的 1-10

页面
每页
清除全部
  1. 7-Ethoxyresorufin
    B5963 7-Ethoxyresorufin
    中文名: 乙氧基试卤灵,7-乙氧基-3H-吩恶嗪-3-酮
    Target: Cytochrome P450 (CYP450)
    Summary: CYP1A特异性底物
      Soluble in DMSO
  2. Quinidine
    B7590 Quinidine
    中文名: 奎尼丁
    Target: Voltage-gated Sodium (NaV) Channels|Cytochrome P450 (CYP450)
    Summary: 降低Na+和K+通道电流
      ≥11.95 mg/mL
      insoluble in H2O
  3. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: eIF4E:eIF4G与eIF4E:4E-BP1相互作用的双重抑制剂
      ≥23.85 mg/mL
      insoluble in H2O
  4. 4EGI-1
    B3696 4EGI-1
     2 Citation
    Target: eIF4E/eIF3G interaction
    Summary: 竞争性的eIF4E/eIF4G相互作用抑制剂。
      ≥22.56 mg/mL
  5. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  6. Fluconazole
    B2094 Fluconazole
    中文名: 氟康唑
    Target: Cytochrome P450 (CYP450)
    Summary: 三唑抗真菌剂
      ≥10.9 mg/mL
      insoluble in H2O
  7. Rifabutin
    B2126 Rifabutin
    中文名: 利福布丁
    Target: Cytochrome P450 (CYP450)
    Summary: 抗结核药物
      ≥42.35 mg/mL
      insoluble in H2O
  8. TOK-001
    A8623 TOK-001
    中文名: 加来特龙,伽来特隆
    Target: Androgen Receptors|Cytochrome P450 (CYP450)
    Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
      ≥12.4 mg/mL
      insoluble in H2O
  9. Clotrimazole
    A8401 Clotrimazole
     2 Citation
    中文名: 克霉唑
    Target: Cytochrome P450 (CYP450)
    Summary: 抗真菌化合物
      ≥28.1 mg/mL
      insoluble in H2O
  10. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL

18件产品中的 1-10

页面
每页